Evidence map›Paper›PMID 37810917›Full record

ArticleFrontiers in nutrition2023

Effect of the Mediterranean diet supplemented with nicotinamide riboside and pterostilbene and/or coconut oil on anthropometric variables in amyotrophic lateral sclerosis. A pilot study.

Sandra Carrera-Juliá, José M Estrela, Mario Zacarés, Mari Ángeles Navarro, María Jesús Vega-Bello, José Enrique de la Rubia Ortí, Mari Luz Moreno, Eraci Drehmer

Registry-linked trialOpen access · goldAbstract read
In one paragraph

Article in Frontiers in nutrition, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT03489200 (EH301 for the Treatment of Amyotrophic Lateral Sclerosis), which is not on this map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
3.5field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT03489200 nacompletednot on this map

EH301 for the Treatment of Amyotrophic Lateral Sclerosis: a Placebo-Controlled Study

TypeinterventionalSponsorElysium HealthRan2017 to 2017Enrolled32ConditionsAmyotrophic Lateral SclerosisArmsEH301, Placebo
3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 17 citations in OpenAlex.

  1. Trial
  2. Review
  3. Regulation of Stem Cell Function by NADPhysiology (Bethesda, Md.) · 2025
    Review
  4. Article
  5. Review
  6. Review
  7. Gut microbiota immune cross-talk in amyotrophic lateral sclerosis.Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics · 2024
    Review
  8. Regulation of and challenges in targeting NADNature reviews. Molecular cell biology · 2024
    Review
  9. The role of nicotinamide adenine dinucleotide salvage enzymes in cardioprotection.Kardiochirurgia i torakochirurgia polska = Polish journal of cardio-thoracic surgery · 2024
    Review
  10. Article
  11. Review
  12. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

Sandra Carrera-JuliáDepartment of Nutrition and Dietetics, Catholic University of Valencia San Vicente Mártir, Valencia, Spain.
José M EstrelaDepartment of Physiology, University of Valencia, Valencia, Spain.
Mario ZacarésDepartment of Basic and Transversal Sciences, Catholic University of Valencia San Vicente Mártir, Valencia, Spain.
Mari Ángeles NavarroDepartment of Basic and Transversal Sciences, Catholic University of Valencia San Vicente Mártir, Valencia, Spain.
María Jesús Vega-BelloDepartment of Human Anatomy and Physiology, Catholic University of Valencia San Vicente Mártir, Valencia, Spain.
José Enrique de la Rubia OrtíDepartment of Nursery, Catholic University of Valencia San Vicente Mártir, Valencia, Spain.
Mari Luz MorenoDepartment of Human Anatomy and Physiology, Catholic University of Valencia San Vicente Mártir, Valencia, Spain.
Eraci DrehmerDepartment of Health and Functional Assessment, Catholic University of Valencia San Vicente Mártir, Valencia, Spain.
Universitat de València · ESValencia Catholic University Saint Vincent Martyr · ES

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Amyotrophic Lateral Sclerosis (ALS) is a chronic and progressive neurodegenerative disease that causes the death of motor neurons and alters patients' body composition. Supplementation with the antioxidants nicotinamide riboside (NR) and pterostilbene (PTER) can combat associated oxidative stress. Additionally, coconut oil is an alternative energy substrate that can address mitochondrial dysfunction. The aim of the present study is to assess the impact of a Mediterranean Diet supplemented with NR and PTER and/or with coconut oil on the anthropometric variables of patients with ALS. A prospective, mixed, randomized, analytical and experimental pilot study in humans was performed through a clinical trial (registered with ClinicalTrials.gov under number NCT03489200) with pre- and post-intervention assessments. The sample was made up of 40 subjects categorized into four study groups (Control, Antioxidants, Coconut oil, and Antioxidants + Coconut oil). Pre- and post-intervention anthropometric assessments were carried out to determine the following data: weight, percentage of fat and muscle mass, skinfolds, body perimeters, Body Mass Index (BMI), Waste-to-Hip Index (WHI) and Waist-Height Ratio (WHR). Compared to the Control group, GAx significantly increased muscle mass percentage and decreased fat mass percentage, triceps, iliac crest, and abdominal skinfolds. GCoco significantly increased muscle mass percentage and decreased fat mass percentage, subscapular skinfolds, and abdominal skinfolds. GAx + coco significantly increased muscle mass percentage and decreased abdominal skinfolds. Therefore, our results suggest that the Mediterranean Diet supplemented with NR and PTER and the Mediterranean Diet supplemented with coconut oil (ketogenic diet) are the two nutritional interventions that have reported the greatest benefits, at anthropometric level.

Indexed as

amyotrophic lateral sclerosisanthropometrycoconut oilnicotinamide ribosidenutritionpterostilbene

Identifiers

PMID37810917
PMCPMC10556480
OpenAlexW4386967538

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.